| 1 | ocular | 2,866 |
| 2 | visceral | 1,733 |
| 3 | hematologic | 931 |
| 4 | hematological | 918 |
| 5 | epicardial | 650 |
| 6 | haematological | 639 |
| 7 | obesity-related | 430 |
| 8 | truncal | 144 |
| 9 | epididymal | 143 |
| 10 | formalin-fixed | 136 |
| 11 | immune-related | 113 |
| 12 | obesity-associated | 112 |
| 13 | extracardiac | 79 |
| 14 | extrapulmonary | 76 |
| 15 | omental | 76 |
| 16 | meningeal | 59 |
| 17 | haematologic | 56 |
| 18 | perirenal | 55 |
| 19 | non-hematologic | 47 |
| 20 | android | 41 |
| 21 | infrapatellar | 40 |
| 22 | intermuscular | 39 |
| 23 | dialysis-related | 28 |
| 24 | extrathoracic | 23 |
| 25 | extra-intestinal | 22 |
| 26 | extra-pulmonary | 21 |
| 27 | non-aids-defining | 20 |
| 28 | non-cns | 20 |
| 29 | lead-induced | 18 |
| 30 | pain-associated | 18 |
| 31 | smoking-associated | 18 |
| 32 | perirectal | 17 |
| 33 | mineralizing | 16 |
| 34 | nonskeletal | 16 |
| 35 | beige | 12 |
| 36 | grade-3 | 12 |
| 37 | oedematous | 11 |
| 38 | gynoid | 9 |
| 39 | iron-related | 9 |
| 40 | non-gastrointestinal | 9 |
| 41 | technique-related | 9 |
| 42 | acetoclastic | 8 |
| 43 | gh-related | 7 |
| 44 | physician-documented | 7 |
| 45 | prevertebral | 7 |
| 46 | dan'e-fukang | 6 |
| 47 | intervalvular | 6 |
| 48 | mri-assessed | 6 |
| 49 | noncutaneous | 6 |
| 50 | unmanageable | 6 |
| 51 | blood-related | 5 |
| 52 | cisplatin-related | 5 |
| 53 | creased | 5 |
| 54 | extra-digestive | 5 |
| 55 | gemistocytic | 5 |
| 56 | nonurological | 5 |
| 57 | sub-mucosal | 5 |
| 58 | asc-enriched | 4 |
| 59 | brite/beige | 4 |
| 60 | formaldehyde-fixed | 4 |
| 61 | microfocal | 4 |
| 62 | moderate/marked | 4 |
| 63 | nonhepatic | 4 |
| 64 | odentogenous | 4 |
| 65 | oxaliplatin-related | 4 |
| 66 | primate-specific | 4 |
| 67 | coronial | 3 |
| 68 | ft/body | 3 |
| 69 | hernia-related | 3 |
| 70 | neuromeningeal | 3 |
| 71 | non-haematologic | 3 |
| 72 | non-hiv-associated | 3 |
| 73 | nonskin | 3 |
| 74 | odontologic | 3 |
| 75 | osseus | 3 |
| 76 | pacap38-induced | 3 |
| 77 | paraquat-mediated | 3 |
| 78 | periodontal-like | 3 |
| 79 | rhinosinusitis-like | 3 |
| 80 | scl-related | 3 |
| 81 | underlaying | 3 |
| 82 | wear-related | 3 |
| 83 | 18.43±2.82 | 2 |
| 84 | 5717 | 2 |
| 85 | bd-mediated | 2 |
| 86 | biofunctionalizing | 2 |
| 87 | chemoradiation-related | 2 |
| 88 | denture-induced | 2 |
| 89 | dermato-venereal | 2 |
| 90 | dorsocervical | 2 |
| 91 | eosinophil-related | 2 |
| 92 | ewd-induced | 2 |
| 93 | fibromyxoid | 2 |
| 94 | g1-3 | 2 |
| 95 | grade-3/4 | 2 |
| 96 | hs-27 | 2 |
| 97 | inacceptable | 2 |
| 98 | l1₂-al₃sc | 2 |
| 99 | microhemodynamic | 2 |
| 100 | mineralocorticoid-mediated | 2 |
| 101 | non-endocrine | 2 |
| 102 | nonadipocytic | 2 |
| 103 | nonassessable | 2 |
| 104 | office-induced | 2 |
| 105 | osteoarthritis-associated | 2 |
| 106 | periepididymal | 2 |
| 107 | periimplant/periodontal | 2 |
| 108 | preparation-related | 2 |
| 109 | renal-specific | 2 |
| 110 | segment-level | 2 |
| 111 | sod1-induced | 2 |
| 112 | stdp-like | 2 |
| 113 | stimulus-aligned | 2 |
| 114 | supervening | 2 |
| 115 | vat/sc | 2 |
| 116 | vat/subcutaneous | 2 |
| 117 | visceral-to-subcutaneous | 2 |
| 118 | visceral/subcutaneous | 2 |
| 119 | vulture-alto | 2 |
| 120 | wound-associated | 2 |
| 121 | 'airway | 1 |
| 122 | 24.08±2.06 | 1 |
| 123 | 5868 | 1 |
| 124 | aklilu | 1 |
| 125 | amelanocitic | 1 |
| 126 | amino-terminated | 1 |
| 127 | ampicillin-induced | 1 |
| 128 | anabolic-when | 1 |
| 129 | anticonvulsant-induced | 1 |
| 130 | asm-released | 1 |
| 131 | ato-related | 1 |
| 132 | atrazine-induced | 1 |
| 133 | bcnu-mediated | 1 |
| 134 | brca1-breast | 1 |
| 135 | bulk-derived | 1 |
| 136 | bur-prepared | 1 |
| 137 | cholesterol-preloaded | 1 |
| 138 | ciclosporin-induced | 1 |
| 139 | clinically-rated | 1 |
| 140 | clinicaltrials.govnct00066703 | 1 |
| 141 | contrast-mediated | 1 |
| 142 | dc-associated | 1 |
| 143 | delayed-typed | 1 |
| 144 | developmnetal | 1 |
| 145 | deyo-charlson | 1 |
| 146 | dye-metal | 1 |
| 147 | embryo-foetal | 1 |
| 148 | exemestane-associated | 1 |
| 149 | extrahematologic | 1 |
| 150 | extralaryngeal | 1 |
| 151 | exxcel | 1 |
| 152 | featuresincluded | 1 |
| 153 | fn-coated | 1 |
| 154 | gradei-ii | 1 |
| 155 | gradeiii-iv | 1 |
| 156 | graphyne-based | 1 |
| 157 | hb-virus | 1 |
| 158 | hip-abdomen | 1 |
| 159 | histochoice-fixed | 1 |
| 160 | hospital-owned | 1 |
| 161 | improve/resolve | 1 |
| 162 | incidence.as | 1 |
| 163 | inhabitable | 1 |
| 164 | inhibitor-specific | 1 |
| 165 | interferon-γ-mediated | 1 |
| 166 | invasive/microinvasive | 1 |
| 167 | ixabepilone-related | 1 |
| 168 | linker-a | 1 |
| 169 | low-joule | 1 |
| 170 | luminal/epithelial | 1 |
| 171 | luminary | 1 |
| 172 | lvedv/body | 1 |
| 173 | mangabey | 1 |
| 174 | mdma-elicited | 1 |
| 175 | menicare™ | 1 |
| 176 | microng | 1 |
| 177 | mineralising | 1 |
| 178 | movement-incurred | 1 |
| 179 | mtx-related | 1 |
| 180 | mucopren | 1 |
| 181 | nano-embedded | 1 |
| 182 | nonexuberant | 1 |
| 183 | nonhemotologic | 1 |
| 184 | obesity-attributable | 1 |
| 185 | oro-pharingeal | 1 |
| 186 | ostecoclastic | 1 |
| 187 | osteoradionecrosis/bone | 1 |
| 188 | panic-depression | 1 |
| 189 | para-articular | 1 |
| 190 | peri-umbilical | 1 |
| 191 | perivisceral | 1 |
| 192 | physical/psychosocial | 1 |
| 193 | pik3ca-activated | 1 |
| 194 | polyq-mediated | 1 |
| 195 | portex® | 1 |
| 196 | post-eruptive | 1 |
| 197 | prrsv-positive | 1 |
| 198 | pud-related | 1 |
| 199 | pusule | 1 |
| 200 | radiance-rich | 1 |
| 201 | regional-stage | 1 |
| 202 | respiratory/intrathoracic | 1 |
| 203 | safetac-based | 1 |
| 204 | safety/possible | 1 |
| 205 | screen-ii | 1 |
| 206 | semi-serial | 1 |
| 207 | sgk3-dependent | 1 |
| 208 | skeleton-less | 1 |
| 209 | skin/oral | 1 |
| 210 | stargazin-mediated | 1 |
| 211 | stomach/esophagus | 1 |
| 212 | supra-crestal | 1 |
| 213 | thickness/cortical | 1 |
| 214 | thigh-intermuscular | 1 |
| 215 | tianji | 1 |
| 216 | tightly-bonded | 1 |
| 217 | tmao-aggravated | 1 |
| 218 | trabeculae-to-implant | 1 |
| 219 | trial-design-driven | 1 |
| 220 | trigno | 1 |
| 221 | ts-induced | 1 |
| 222 | tubal/peritoneal | 1 |
| 223 | type-evaluated | 1 |
| 224 | visceral/sub-cutaneous | 1 |
| 225 | vision/hearing-related | 1 |
| 226 | xindi | 1 |
| 1 | 'airway | 1 |
| 2 | 18.43±2.82 | 2 |
| 3 | 24.08±2.06 | 1 |
| 4 | 5717 | 2 |
| 5 | 5868 | 1 |
| 6 | acetoclastic | 8 |
| 7 | aklilu | 1 |
| 8 | amelanocitic | 1 |
| 9 | amino-terminated | 1 |
| 10 | ampicillin-induced | 1 |
| 11 | anabolic-when | 1 |
| 12 | android | 41 |
| 13 | anticonvulsant-induced | 1 |
| 14 | asc-enriched | 4 |
| 15 | asm-released | 1 |
| 16 | ato-related | 1 |
| 17 | atrazine-induced | 1 |
| 18 | bcnu-mediated | 1 |
| 19 | bd-mediated | 2 |
| 20 | beige | 12 |
| 21 | biofunctionalizing | 2 |
| 22 | blood-related | 5 |
| 23 | brca1-breast | 1 |
| 24 | brite/beige | 4 |
| 25 | bulk-derived | 1 |
| 26 | bur-prepared | 1 |
| 27 | chemoradiation-related | 2 |
| 28 | cholesterol-preloaded | 1 |
| 29 | ciclosporin-induced | 1 |
| 30 | cisplatin-related | 5 |
| 31 | clinically-rated | 1 |
| 32 | clinicaltrials.govnct00066703 | 1 |
| 33 | contrast-mediated | 1 |
| 34 | coronial | 3 |
| 35 | creased | 5 |
| 36 | dan'e-fukang | 6 |
| 37 | dc-associated | 1 |
| 38 | delayed-typed | 1 |
| 39 | denture-induced | 2 |
| 40 | dermato-venereal | 2 |
| 41 | developmnetal | 1 |
| 42 | deyo-charlson | 1 |
| 43 | dialysis-related | 28 |
| 44 | dorsocervical | 2 |
| 45 | dye-metal | 1 |
| 46 | embryo-foetal | 1 |
| 47 | eosinophil-related | 2 |
| 48 | epicardial | 650 |
| 49 | epididymal | 143 |
| 50 | ewd-induced | 2 |
| 51 | exemestane-associated | 1 |
| 52 | extra-digestive | 5 |
| 53 | extra-intestinal | 22 |
| 54 | extra-pulmonary | 21 |
| 55 | extracardiac | 79 |
| 56 | extrahematologic | 1 |
| 57 | extralaryngeal | 1 |
| 58 | extrapulmonary | 76 |
| 59 | extrathoracic | 23 |
| 60 | exxcel | 1 |
| 61 | featuresincluded | 1 |
| 62 | fibromyxoid | 2 |
| 63 | fn-coated | 1 |
| 64 | formaldehyde-fixed | 4 |
| 65 | formalin-fixed | 136 |
| 66 | ft/body | 3 |
| 67 | g1-3 | 2 |
| 68 | gemistocytic | 5 |
| 69 | gh-related | 7 |
| 70 | grade-3 | 12 |
| 71 | grade-3/4 | 2 |
| 72 | gradei-ii | 1 |
| 73 | gradeiii-iv | 1 |
| 74 | graphyne-based | 1 |
| 75 | gynoid | 9 |
| 76 | haematologic | 56 |
| 77 | haematological | 639 |
| 78 | hb-virus | 1 |
| 79 | hematologic | 931 |
| 80 | hematological | 918 |
| 81 | hernia-related | 3 |
| 82 | hip-abdomen | 1 |
| 83 | histochoice-fixed | 1 |
| 84 | hospital-owned | 1 |
| 85 | hs-27 | 2 |
| 86 | immune-related | 113 |
| 87 | improve/resolve | 1 |
| 88 | inacceptable | 2 |
| 89 | incidence.as | 1 |
| 90 | infrapatellar | 40 |
| 91 | inhabitable | 1 |
| 92 | inhibitor-specific | 1 |
| 93 | interferon-γ-mediated | 1 |
| 94 | intermuscular | 39 |
| 95 | intervalvular | 6 |
| 96 | invasive/microinvasive | 1 |
| 97 | iron-related | 9 |
| 98 | ixabepilone-related | 1 |
| 99 | l1₂-al₃sc | 2 |
| 100 | lead-induced | 18 |
| 101 | linker-a | 1 |
| 102 | low-joule | 1 |
| 103 | luminal/epithelial | 1 |
| 104 | luminary | 1 |
| 105 | lvedv/body | 1 |
| 106 | mangabey | 1 |
| 107 | mdma-elicited | 1 |
| 108 | menicare™ | 1 |
| 109 | meningeal | 59 |
| 110 | microfocal | 4 |
| 111 | microhemodynamic | 2 |
| 112 | microng | 1 |
| 113 | mineralising | 1 |
| 114 | mineralizing | 16 |
| 115 | mineralocorticoid-mediated | 2 |
| 116 | moderate/marked | 4 |
| 117 | movement-incurred | 1 |
| 118 | mri-assessed | 6 |
| 119 | mtx-related | 1 |
| 120 | mucopren | 1 |
| 121 | nano-embedded | 1 |
| 122 | neuromeningeal | 3 |
| 123 | non-aids-defining | 20 |
| 124 | non-cns | 20 |
| 125 | non-endocrine | 2 |
| 126 | non-gastrointestinal | 9 |
| 127 | non-haematologic | 3 |
| 128 | non-hematologic | 47 |
| 129 | non-hiv-associated | 3 |
| 130 | nonadipocytic | 2 |
| 131 | nonassessable | 2 |
| 132 | noncutaneous | 6 |
| 133 | nonexuberant | 1 |
| 134 | nonhemotologic | 1 |
| 135 | nonhepatic | 4 |
| 136 | nonskeletal | 16 |
| 137 | nonskin | 3 |
| 138 | nonurological | 5 |
| 139 | obesity-associated | 112 |
| 140 | obesity-attributable | 1 |
| 141 | obesity-related | 430 |
| 142 | ocular | 2,866 |
| 143 | odentogenous | 4 |
| 144 | odontologic | 3 |
| 145 | oedematous | 11 |
| 146 | office-induced | 2 |
| 147 | omental | 76 |
| 148 | oro-pharingeal | 1 |
| 149 | osseus | 3 |
| 150 | ostecoclastic | 1 |
| 151 | osteoarthritis-associated | 2 |
| 152 | osteoradionecrosis/bone | 1 |
| 153 | oxaliplatin-related | 4 |
| 154 | pacap38-induced | 3 |
| 155 | pain-associated | 18 |
| 156 | panic-depression | 1 |
| 157 | para-articular | 1 |
| 158 | paraquat-mediated | 3 |
| 159 | peri-umbilical | 1 |
| 160 | periepididymal | 2 |
| 161 | periimplant/periodontal | 2 |
| 162 | periodontal-like | 3 |
| 163 | perirectal | 17 |
| 164 | perirenal | 55 |
| 165 | perivisceral | 1 |
| 166 | physical/psychosocial | 1 |
| 167 | physician-documented | 7 |
| 168 | pik3ca-activated | 1 |
| 169 | polyq-mediated | 1 |
| 170 | portex® | 1 |
| 171 | post-eruptive | 1 |
| 172 | preparation-related | 2 |
| 173 | prevertebral | 7 |
| 174 | primate-specific | 4 |
| 175 | prrsv-positive | 1 |
| 176 | pud-related | 1 |
| 177 | pusule | 1 |
| 178 | radiance-rich | 1 |
| 179 | regional-stage | 1 |
| 180 | renal-specific | 2 |
| 181 | respiratory/intrathoracic | 1 |
| 182 | rhinosinusitis-like | 3 |
| 183 | safetac-based | 1 |
| 184 | safety/possible | 1 |
| 185 | scl-related | 3 |
| 186 | screen-ii | 1 |
| 187 | segment-level | 2 |
| 188 | semi-serial | 1 |
| 189 | sgk3-dependent | 1 |
| 190 | skeleton-less | 1 |
| 191 | skin/oral | 1 |
| 192 | smoking-associated | 18 |
| 193 | sod1-induced | 2 |
| 194 | stargazin-mediated | 1 |
| 195 | stdp-like | 2 |
| 196 | stimulus-aligned | 2 |
| 197 | stomach/esophagus | 1 |
| 198 | sub-mucosal | 5 |
| 199 | supervening | 2 |
| 200 | supra-crestal | 1 |
| 201 | technique-related | 9 |
| 202 | thickness/cortical | 1 |
| 203 | thigh-intermuscular | 1 |
| 204 | tianji | 1 |
| 205 | tightly-bonded | 1 |
| 206 | tmao-aggravated | 1 |
| 207 | trabeculae-to-implant | 1 |
| 208 | trial-design-driven | 1 |
| 209 | trigno | 1 |
| 210 | truncal | 144 |
| 211 | ts-induced | 1 |
| 212 | tubal/peritoneal | 1 |
| 213 | type-evaluated | 1 |
| 214 | underlaying | 3 |
| 215 | unmanageable | 6 |
| 216 | vat/sc | 2 |
| 217 | vat/subcutaneous | 2 |
| 218 | visceral | 1,733 |
| 219 | visceral-to-subcutaneous | 2 |
| 220 | visceral/sub-cutaneous | 1 |
| 221 | visceral/subcutaneous | 2 |
| 222 | vision/hearing-related | 1 |
| 223 | vulture-alto | 2 |
| 224 | wear-related | 3 |
| 225 | wound-associated | 2 |
| 226 | xindi | 1 |
| 1 | 18.43±2.82 | 2 |
| 2 | g1-3 | 2 |
| 3 | grade-3 | 12 |
| 4 | clinicaltrials.govnct00066703 | 1 |
| 5 | grade-3/4 | 2 |
| 6 | 24.08±2.06 | 1 |
| 7 | 5717 | 2 |
| 8 | hs-27 | 2 |
| 9 | 5868 | 1 |
| 10 | linker-a | 1 |
| 11 | extracardiac | 79 |
| 12 | respiratory/intrathoracic | 1 |
| 13 | extrathoracic | 23 |
| 14 | primate-specific | 4 |
| 15 | renal-specific | 2 |
| 16 | inhibitor-specific | 1 |
| 17 | haematologic | 56 |
| 18 | non-haematologic | 3 |
| 19 | hematologic | 931 |
| 20 | non-hematologic | 47 |
| 21 | extrahematologic | 1 |
| 22 | odontologic | 3 |
| 23 | nonhemotologic | 1 |
| 24 | microhemodynamic | 2 |
| 25 | nonhepatic | 4 |
| 26 | amelanocitic | 1 |
| 27 | ostecoclastic | 1 |
| 28 | acetoclastic | 8 |
| 29 | nonadipocytic | 2 |
| 30 | gemistocytic | 5 |
| 31 | vat/sc | 2 |
| 32 | l1₂-al₃sc | 2 |
| 33 | sod1-induced | 2 |
| 34 | pacap38-induced | 3 |
| 35 | lead-induced | 18 |
| 36 | ewd-induced | 2 |
| 37 | office-induced | 2 |
| 38 | atrazine-induced | 1 |
| 39 | denture-induced | 2 |
| 40 | ampicillin-induced | 1 |
| 41 | ciclosporin-induced | 1 |
| 42 | ts-induced | 1 |
| 43 | anticonvulsant-induced | 1 |
| 44 | cholesterol-preloaded | 1 |
| 45 | nano-embedded | 1 |
| 46 | tightly-bonded | 1 |
| 47 | featuresincluded | 1 |
| 48 | asc-enriched | 4 |
| 49 | moderate/marked | 4 |
| 50 | stimulus-aligned | 2 |
| 51 | hospital-owned | 1 |
| 52 | delayed-typed | 1 |
| 53 | bur-prepared | 1 |
| 54 | movement-incurred | 1 |
| 55 | safetac-based | 1 |
| 56 | graphyne-based | 1 |
| 57 | asm-released | 1 |
| 58 | creased | 5 |
| 59 | mri-assessed | 6 |
| 60 | dc-associated | 1 |
| 61 | wound-associated | 2 |
| 62 | exemestane-associated | 1 |
| 63 | smoking-associated | 18 |
| 64 | pain-associated | 18 |
| 65 | osteoarthritis-associated | 2 |
| 66 | non-hiv-associated | 3 |
| 67 | obesity-associated | 112 |
| 68 | bd-mediated | 2 |
| 69 | mineralocorticoid-mediated | 2 |
| 70 | stargazin-mediated | 1 |
| 71 | polyq-mediated | 1 |
| 72 | paraquat-mediated | 3 |
| 73 | contrast-mediated | 1 |
| 74 | bcnu-mediated | 1 |
| 75 | interferon-γ-mediated | 1 |
| 76 | hernia-related | 3 |
| 77 | blood-related | 5 |
| 78 | pud-related | 1 |
| 79 | ixabepilone-related | 1 |
| 80 | immune-related | 113 |
| 81 | technique-related | 9 |
| 82 | vision/hearing-related | 1 |
| 83 | gh-related | 7 |
| 84 | scl-related | 3 |
| 85 | eosinophil-related | 2 |
| 86 | oxaliplatin-related | 4 |
| 87 | cisplatin-related | 5 |
| 88 | chemoradiation-related | 2 |
| 89 | preparation-related | 2 |
| 90 | iron-related | 9 |
| 91 | ato-related | 1 |
| 92 | wear-related | 3 |
| 93 | dialysis-related | 28 |
| 94 | mtx-related | 1 |
| 95 | obesity-related | 430 |
| 96 | amino-terminated | 1 |
| 97 | fn-coated | 1 |
| 98 | clinically-rated | 1 |
| 99 | type-evaluated | 1 |
| 100 | tmao-aggravated | 1 |
| 101 | pik3ca-activated | 1 |
| 102 | mdma-elicited | 1 |
| 103 | physician-documented | 7 |
| 104 | bulk-derived | 1 |
| 105 | histochoice-fixed | 1 |
| 106 | formaldehyde-fixed | 4 |
| 107 | formalin-fixed | 136 |
| 108 | gynoid | 9 |
| 109 | android | 41 |
| 110 | fibromyxoid | 2 |
| 111 | regional-stage | 1 |
| 112 | beige | 12 |
| 113 | brite/beige | 4 |
| 114 | periodontal-like | 3 |
| 115 | stdp-like | 2 |
| 116 | rhinosinusitis-like | 3 |
| 117 | unmanageable | 6 |
| 118 | nonassessable | 2 |
| 119 | inhabitable | 1 |
| 120 | inacceptable | 2 |
| 121 | obesity-attributable | 1 |
| 122 | safety/possible | 1 |
| 123 | low-joule | 1 |
| 124 | pusule | 1 |
| 125 | non-endocrine | 2 |
| 126 | osteoradionecrosis/bone | 1 |
| 127 | invasive/microinvasive | 1 |
| 128 | prrsv-positive | 1 |
| 129 | post-eruptive | 1 |
| 130 | extra-digestive | 5 |
| 131 | improve/resolve | 1 |
| 132 | dan'e-fukang | 6 |
| 133 | supervening | 2 |
| 134 | non-aids-defining | 20 |
| 135 | mineralising | 1 |
| 136 | underlaying | 3 |
| 137 | biofunctionalizing | 2 |
| 138 | mineralizing | 16 |
| 139 | microng | 1 |
| 140 | radiance-rich | 1 |
| 141 | xindi | 1 |
| 142 | gradei-ii | 1 |
| 143 | screen-ii | 1 |
| 144 | tianji | 1 |
| 145 | nonurological | 5 |
| 146 | haematological | 639 |
| 147 | hematological | 918 |
| 148 | peri-umbilical | 1 |
| 149 | thickness/cortical | 1 |
| 150 | dorsocervical | 2 |
| 151 | truncal | 144 |
| 152 | microfocal | 4 |
| 153 | meningeal | 59 |
| 154 | neuromeningeal | 3 |
| 155 | oro-pharingeal | 1 |
| 156 | extralaryngeal | 1 |
| 157 | tubal/peritoneal | 1 |
| 158 | dermato-venereal | 2 |
| 159 | physical/psychosocial | 1 |
| 160 | epicardial | 650 |
| 161 | luminal/epithelial | 1 |
| 162 | coronial | 3 |
| 163 | semi-serial | 1 |
| 164 | epididymal | 143 |
| 165 | periepididymal | 2 |
| 166 | perirenal | 55 |
| 167 | extra-intestinal | 22 |
| 168 | non-gastrointestinal | 9 |
| 169 | prevertebral | 7 |
| 170 | visceral | 1,733 |
| 171 | perivisceral | 1 |
| 172 | skin/oral | 1 |
| 173 | sub-mucosal | 5 |
| 174 | perirectal | 17 |
| 175 | nonskeletal | 16 |
| 176 | dye-metal | 1 |
| 177 | developmnetal | 1 |
| 178 | embryo-foetal | 1 |
| 179 | omental | 76 |
| 180 | periimplant/periodontal | 2 |
| 181 | supra-crestal | 1 |
| 182 | exxcel | 1 |
| 183 | segment-level | 2 |
| 184 | anabolic-when | 1 |
| 185 | hip-abdomen | 1 |
| 186 | mucopren | 1 |
| 187 | trial-design-driven | 1 |
| 188 | nonskin | 3 |
| 189 | panic-depression | 1 |
| 190 | deyo-charlson | 1 |
| 191 | trigno | 1 |
| 192 | vulture-alto | 2 |
| 193 | infrapatellar | 40 |
| 194 | para-articular | 1 |
| 195 | ocular | 2,866 |
| 196 | intermuscular | 39 |
| 197 | thigh-intermuscular | 1 |
| 198 | intervalvular | 6 |
| 199 | incidence.as | 1 |
| 200 | non-cns | 20 |
| 201 | skeleton-less | 1 |
| 202 | osseus | 3 |
| 203 | stomach/esophagus | 1 |
| 204 | visceral/sub-cutaneous | 1 |
| 205 | visceral-to-subcutaneous | 2 |
| 206 | visceral/subcutaneous | 2 |
| 207 | vat/subcutaneous | 2 |
| 208 | noncutaneous | 6 |
| 209 | odentogenous | 4 |
| 210 | oedematous | 11 |
| 211 | hb-virus | 1 |
| 212 | trabeculae-to-implant | 1 |
| 213 | nonexuberant | 1 |
| 214 | sgk3-dependent | 1 |
| 215 | brca1-breast | 1 |
| 216 | aklilu | 1 |
| 217 | gradeiii-iv | 1 |
| 218 | 'airway | 1 |
| 219 | ft/body | 3 |
| 220 | lvedv/body | 1 |
| 221 | mangabey | 1 |
| 222 | luminary | 1 |
| 223 | extra-pulmonary | 21 |
| 224 | extrapulmonary | 76 |
| 225 | menicare™ | 1 |
| 226 | portex® | 1 |